Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuritin-1 like protein (NRN1L) is a human protein encoded by the NRN1L gene and is a member of an activity-regulated ligand family expressed in the nervous system[6][8]. It shares structural similarity with neuritin-1 (NRN1/CPG15) and is thought to be involved in the promotion of neurite growth, neuronal arborization, and neuronal survival during development and differentiation, similar to its paralogue neuritin-1[6][8][1]. NRN1L is predominantly expressed in the nervous system, and animal studies suggest it may participate in neuronal development, plasticity, and potentially the pathogenesis of neurodevelopmental diseases[3][6][8]. While NRN1 (neuritin-1) is being investigated for neuroprotective and regenerative roles, direct evidence linking NRN1L to human disease or its use as a therapeutic target is currently lacking, and its exact molecular mechanism, interacting partners, and disease associations remain insufficiently characterized[1][3][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuritin-1 like protein (NRN1L).